Features | Partner Sites | Information | LinkXpress
Sign In
Demo Company

Global Computational Biology Sector Expected to Reach over USD 4 Billion by 2020

By BiotechDaily International staff writers
Posted on 17 Aug 2014
The global market for computational biology is expected to reach USD 4.285 billion by 2020 growing at a compound annual growth rate (CAGR) of 21.1%, according to new market research.

Steady surge in the usage and application of computational biology for bioinformatics R&D programs designed for sequencing genomes to better determine biologic systems and increasing number of clinical studies in pharmacogenomics and pharmacokinetics for novel drug discovery studies are expected to drive computational biology demand over the next six years, according to a recent market report published by Grand View Research, Inc. (San Francisco, CA,USA), a market research and consulting company.

Computational genomics for cellular and biologic simulation applications lead the market in 2013, accounting for over 47% of global revenue. Major factors fueling demand for these applications include the growth of drug designing, disease modeling and personalized medicine applications and the growing usage of computational biology for functional and structural genomics, epigenomics and metagenomics for the analysis of protein transcription, protein-protein interactions, gene sequencing and expression and three-dimensional (3D) protein structure analysis.

Further key findings from the study suggest that North America was the largest regional market, accounting for 58.0% of the global revenue in 2013. Its large share is mostly credited to the growing research investments and initiatives for development of drug discovery, disease modeling technologies and advances in biologic computation technology. It is expected that Asia Pacific will see the most rapid growth in the market, at an estimated CAGR of 28.0% due to the increasing expenditure in clinical studies for pharmacokinetics and pharmacogenomics.

Another finding included that the application of computational biology in proteomics for cellular simulation is expected to grow at the fastest CAGR of over 22%, due to the swing in sequencing studies towards additional analysis of the nature of various biologic proteins as a part of development of personalized medicine.

Drug discovery and disease modelling applications were found to dominate the market, accounting for 58.0% of global revenue in 2013. This large share is attributed by the extensive drug development pipelines present for a number of global branded and generic drug manufacturing firms such as Sanofi, Novo Nordisk, and Eli Lilly.

Computational Biology databases dominated the tools segment and accounted for 44.5% of the market revenue in 2013, owing to extensive genomic database usage for warehousing and data mining of biologic and sequential data generated from genomic and proteomic studies. Consequentially, the software and services for the analysis of biologic data is expected to witness the fastest CAGR of over 21.0%. Major companies in this market include Schrodinger, Accelrys, Certara, Entelos, Simulation Plus, and others.

Grand View Research provides customized research reports and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials, and energy.

Related Links:

Grand View Research



view channel
Image: Micrograph showing immunofluorescence of skin differentiation markers for basal keratinocytes (Photo courtesy of Dr. Russ Carstens, University of Pennsylvania).

Alternate Splicing Proteins Critically Linked to Skin and Organ Development

Two proteins that regulate alternative splicing in epithelial cells have been linked to the proper development of the skin and protective layers that surround other organs in the body. Two steps are... Read more

Drug Discovery

view channel
Image: Endoscopic image of a bowel section known as the sigmoid colon afflicted with ulcerative colitis. The internal surface of the colon is blotchy and broken in places (Photo courtesy of Wikimedia Commons).

Orally Delivered Curcumin-Loaded Microparticles Effectively Treat Mouse Model of Ulcerative Colitis

Microparticles (MPs) loaded with the efficient anti-inflammatory agent curcumin were found to effectively treat a mouse model of ulcerative colitis. Ulcerative colitis is a chronic relapsing disease... Read more

Lab Technologies

view channel

New Genomic Research Kit Simplifies Exome Studies

An exciting new tool is now available for biotech researchers working in the field of genomic analysis. The human exome is critical to our genetic make-up and is generally accepted as having the greatest influence on how the genetic blueprint is utilized. The exome is defined as all coding exons in the genome and is... Read more


17 Oct 2015 - 21 Oct 2015
25 Oct 2015 - 29 Oct 2015
16 Nov 2015 - 19 Nov 2015
Copyright © 2000-2015 Globetech Media. All rights reserved.